Bleichroeder’s NeuroOne Medical Technologies NMTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$687K Hold
666,666
– – 0.07% 76
2026
Q2
$2.03M Sell
666,666
-1
-0% -$4 0.36% 34
2026
Q1
$3.11M Hold
666,667
– – 0.54% 25
2025
Q4
$3.03M Hold
666,667
– – 0.53% 24
2025
Q3
$3.55M Hold
666,667
– – 0.69% 20
2025
Q2
$2.71M Buy
+666,667
New +$2.46M 0.67% 18
2022
Q1
– Sell
-62,500
Closed -$728K – 115
2021
Q4
$728K Buy
+62,500
New +$1.01M 0.11% 56

Other funds holding NMTC

Bleichroeder's NMTC Position: Q3 2026 in Review

Bleichroeder held its NeuroOne Medical Technologies (NMTC) position steady in Q3 2026 at 666,666 shares worth $687K. The position accounts for 0.07% of the portfolio, ranked #76.

Bleichroeder first reported a position in NMTC in Q4 2021 and has held it in 7 quarters since. The position peaked at $3.55M in Q3 2025. 18 funds tracked by Wall St. Rank hold NMTC as of Q3 2026.

  • Bleichroeder held 666,666 shares of NeuroOne Medical Technologies worth $687K as of Q3 2026.
  • Bleichroeder left its NeuroOne Medical Technologies share count unchanged in Q3 2026.
  • NeuroOne Medical Technologies made up 0.07% of Bleichroeder's portfolio in Q3 2026, its #76 holding.
  • Bleichroeder first reported a position in NeuroOne Medical Technologies in Q4 2021 and has held it in 7 quarters since.
  • Bleichroeder's NeuroOne Medical Technologies position peaked at $3.55M in Q3 2025.
  • 18 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q3 2026.

Based on Bleichroeder's 13F filing for Q3 2026, filed 13 Nov 2026.